Advanced Psychedelic-Assisted Therapy Certification Program
This course is for anyone who wants to gain an understanding of psychedelic medicine and its therapeutic applications.
Expand to Read More
Course completion will allow you to confidently answer questions from your client/patients and hold informative conversation with your peers on psychedelic- assisted therapy. ATMA’s Advanced Psychedelic-Assisted Therapy Certification program provides you with the foundational knowledge required to advance into the delivery of psychedelic medicine with clients.
Research continues to support the use of psychedelic medicine to treat mental health conditions. As this treatment gains evidence-based status, all practitioners from physicians to therapists to facilitators will benefit from expanding their knowledge of mental health intervention to include psychedelic therapy options.
Several provinces, states, and counties have begun to introduce legislative changes and regulatory guidelines that support the use of psychedelic medicine.
Program Info
at a Glance
Program Available
September 22, 2023
Fees
$2,897 USD
Program Live Q&A Sessions
Monday evenings @ 6:00pm MST
6 monthly starting October 2023
Number of Hours
60 hours online learning at your own pace (plus live Q&A)
Program Overview
Psychedelic-assisted psychotherapy is poised to be an important breakthrough in the treatment of mental illness in this generation. Regulations and guidelines for psychedelic therapy are being implemented, drafted and discussed globally and the momentum is gaining speed.
This ATMA training program will provide comprehensive knowledge, skills and attitudes required to provide effective and ethical psychedelic-assisted psychotherapy. Candidates for this course will be practitioners ranging from physicians to psychiatrists to therapists and wholistic therapy providers, who possess a passion for the field of psychedelic therapy and have an interest in developing a pathway to practice in this area.
The program features evidence-based knowledge and teachings from multiple perspectives with a strong emphasis on safe and ethical practice. This training course will prepare students to be able to confidently answer client/patient questions about psychedelic assisted therapy, lead discussions in this new field as well as begin to explore some legal avenues to offer the therapy.
As regulatory approvals are achieved, the demand for quality training programs will quickly exceed the supply. Health Canada has approved psilocybin-assisted therapy for end of life as well as Major Depressive Disorder (MDD) and MDMA-assisted therapy for Post-Traumatic Stress Disorder (PTSD) through the Special Access Program (SAP). Oregon currently is in the process of licensing psilocybin facilitation centers, and Colorado will follow in 2024. Alberta professional bodies releasing draft practice standards and Australia announcing legalization of MDMA and psilocybin for mental health treatments. We expect that the global momentum towards regulated psychedelic therapy will greatly increase in the next 12-24 months, where thousands of practitioners will be seeking training.
By completing your psychedelic-assisted therapy training now, and by staying up-to-date with the latest research, properly trained practitioners will be in the unique position to offer psychedelic-assisted therapy ethically and competently offer this therapy within regulations coming into effect incrementally. Beat the rush and avoid waitlists by training now.
Upon program completion, students will:
- Understand the history of and current research on psychedelics, including traditional history and uses.
- Gain knowledge of the pharmacology, drug interactions, and adverse events associated with psychedelics, with a focus on psilocybin, MDMA and Ketamine
- Understand the state of current research on micro-dosing psychedelics.
- Develop awareness of the applications of psychedelic-assisted therapy with multiple different psilocybin, MDMA and Ketamine and their utility for treatment of conditions such as major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, and end-of-life distress.
- Identify solutions which address access for marginalized populations as well as ethical considerations for inclusivity in LGTBQA+ communities in psychedelic assisted psychotherapy
- Understand non-ordinary states of consciousness, including psychedelic and non-psychedelic experiences.
- Understand the unique competencies required for safe and ethical facilitation of PaT
- Articulate the code of ethics which guide the implementation of PaT
- Understand the importance of mentorship, peer support and consultation and it’s importance in a sustainable and ethically sound PaT practice.
- Understand what is required to safely and effectively deliver PaT, including preparation of the client and environment for the medicine session
- Gain competency in the art of supporting a client’s integration process, including gaining knowledge on complementary modalities such as ACT or IFS.
- Engage in hands-on coaching and small group learning to solidify the didactic course content.
- Engage in a first-hand experience with psilocybin in a Health Canada Clinical Trial to experientially understand the healing and transformational potential for their clients.
- Understand the importance of self-care as a PaT facilitator and create a personal plan to promote wellness and sustainability in their practice.
The Advanced Psychedelic-Assisted Therapy Certification Program will be delivered in a structure that includes self-paced virtual learning and live Q&A.
The program format is as follows:
- 11 modules of pre-recorded lectures (over 60 hours of study content) that students can watch and review at their own pace, taught by world-class instructors in the field.
- 6 x Monthly Live virtual Q&A’s on Mondays from 6-7 pm MST facilitated by our expert instructors, providing an opportunity to ask any questions and interact with other students. Recordings of each session will be made available for those who cannot attend live.
- Over 100 Downloadable resources, tools and links to recommended further reading
- 11 Multiple Choice Module Reviews. These are not graded and are intended as an opportunity for review only.
We Support Your Journey Towards Offering Safe and Effective Psychedelic-Assisted Therapy
Our mission is to increase the number of practitioners who are thoroughly and ethically trained in the delivery of PaT. We provide a world class faculty and guest presenters who are experts in the field psychedelic medicine.
Our training programs are clinically relevant, and while we provide the academic knowledge that is required to practice in this field safely and ethically, we believe that after training support must accompany theoretical concepts. Our students will gain invaluable knowledge, experience, and self-care support as they work to integrate psychedelic therapy into their existing therapy practices.
Our commitment to our students does not stop after our education and training programs end. We have designed systems, networks, and infrastructure to support practitioners through the entire process of adopting psychedelic-assisted therapy into practice.
With our Community Business Platform, practitioner can feel supported and will have all the resources required to adopt and provide psychedelic-assisted therapy.
Fall Start
- On September 22th, 2023. Students will be able to gain access to online course content.
- Live Q and A Sessions: 60 minutes live Q and A sessions will occur on-going monthly basis commencing in October 2023 on Monday evenings from 6:00-7:00pm MST. Dates will be announced prior to September 22, 2023. Recording will be available for those who cannot attend live.
OUR CURRICULUM
View the lesson plan
An overview of the psychedelic landscape, diving into history, and the current study being done in Psychedelic therapy.
Learn the various compounds and medicines being used under the “Psychedelic” umbrella, including Psilocybin, LSD, MDMA and other lesser known molecules.
Learn from various perspectives on the issues and concerns as this field develops are addressed, including Indigenous, marginalized people groups access, and LGBTQ+ considerations.
Altered states of consciousness covers more than doing a journey with psychedelics, and in this module we explore other modalities including mystical experiences, Yoga, breathwork, cannabis, and more.
The importance of a guide/therapist/coach in the process of psychedelic therapy is key to success in this work. This module discusses the roles of those leading the medicine work, and how best to approach this field as a therapist/counselor etc.
The importance of a guide/therapist/coach in the process of psychedelic therapy is key to success in this work. This module discusses the roles of those leading the medicine work, and how best to approach this field as a therapist/counselor etc.
Overview of “Set”, Screening for Safe and Optimal Experiences, Preparing the Client for PaT, and Effective Modalities for Preparing the Client.
Importance of the Physical, Social, and Cultural Environment, Elements of the Treatment Space, the Role of Music, and Individual vs. Group Experiences.
Importance of Integration, Integration Models, and Individual and Group Integration Considerations. Unpacking the client/patient’s experience with psychedelics.
Choosing the Correct Psychedelic for the Client, Addressing Issues including Addictions, PTSD, Palliative Care, Depression and Anxiety, Relationship Counseling, and Leadership/Personal Awareness/Enhancement.
Working with other modalities in partnership with psychedelics can bring added effectiveness to the therapy sessions. Covering modalities like IFS, ACT, Grof’s cartography of the psyche and others, we dive into the synergy and effectiveness of bringing these modalities together with psychedelic work.
INSTRUCTORS
Featuring a number of leading experts
Mark Haden
VP of Clearmind Medicine, Adjunct Prof., UBC
Erika Dyck
Prof. & Canadian Research Chair, USask
Saundra Jain
Adjunct Clinical Affiliate, School of Nursing, UT Austin
Ian Mitchell
Emergency Physician & Associate Clinical Prof., UBC
Devon Christie
Clinical Instructor, UBC, Family Physician
Bruce Sanguin
Clinical Fellow at CAMFT, Psychotherapist
Trevor Millar
Board Member, Canadian Psychedelic Association
Mike Mathers
Addictions and Trauma Therapist
Natalie Bergstrom
Program Director, ATMA Journey Centers
Dr. Anthony Bossis
PhD, Clinical Assistant Professor, Department of Psychiatry NYU
Philippe Lucas
PhD
GET NOTIFIED
